Suburethral Sling Procedures
Vincent R. Lucente and Marisa A. Mastropietro
Table Of Contents
|Vincent R. Lucente, MD, MBA
Interim Chairman, Department of Obstetrics and Gynecology; Chief, Division of Gynecology; Chief, Section of Urognyecology and Reconstructive Pelvic Surgery, Lehigh Valley Hospital, Allentown, Pennsylovania; Associate Professor of Clinical Obstetrics and Gynecology, Pennsylvania State Univeristy College of Medicine/Hershey Medical Center (Vol 1, Chap 94)
Marisa A. Mastropietro, MD
Associate Chief, Section of Urogynecology and Reconstructive Pelvic Surgery, Lehigh Valley Hospital, Allentown, Pennsylvania (Vol 1, Chap 94)
INTRINSIC SPHINCTER DEFICIENCY
In treating any patient with urinary incontinence, the goal is to provide the patient with a cure from her symptoms and improve her quality of life. To obtain this goal consistently, considering the variability among patients and the multiple factors contributing to the development of incontinence, physicians must be well aware of the various treatment options and their indications. Suburethral sling procedures have long been a mainstay in the surgical treatment for female stress urinary incontinence.
Traditionally, suburethral sling procedures were reserved for patients with recurrent stress urinary incontinence. During the past century, indications have been expanded to include not only those patients with the severe form of stress urinary incontinence, namely intrinsic sphincter deficiency (ISD), but also patients with routine stress incontinence in conjunction with comorbid conditions.
With hopes of improving the treatment of stress incontinence symptoms, interest in primary and secondary slings has increased. The sling procedure is now often considered in any patient with stress urinary incontinence. The suburethral sling procedure requires careful attention to patient selection, workup, surgical technique, and avoidance of complications. The history of the sling procedure, patient evaluation and indications, surgical techniques, and complications of the sling procedure will be discussed here.
Since the first reported case in the early 1900s, the suburethral sling procedure has seen many changes. All aspects of the sling, including its indications, materials, and techniques used, have undergone a generation of change. With each change, there was improvement on the previous modification.
The earliest described sling procedure was in 1907 by Giordano, who used the gracilis muscle. In 1926, Giordano's technique was applied to a case of epispadias by Denning. In 1910, Goebell first described the use of freed pyramidalis muscle suburethrally. This was followed in 1914 by Fragenheim's modification of Goebell's technique, which employed fascial attachments of the pyramidalis muscles and the recommendation for use of the rectus abdominis muscles when the pyramidalis muscles were inadequate. The final modification to this technique in 1917 was by Stoeckel, who combined a vaginal plastic operation with muscular plication at the vesical neck. This is known as the Goebell-Fragenheim-Stoeckel technique.
Further modifications of the sling procedure were reported in 1923 by Thompson, using rectus muscle and fascia, and later in 1929 by Martius, using bulbocavernosus muscle and its surrounding fatty tissue transplanted suburethrally.1
In the early 20th century, sling procedures were described that included the use of a number of autologous grafts. Muscle sling grafts were later abandoned secondary to difficulty in maintaining an adequate vascular and neural supply and therefore a viable graft. In 1942, Aldridge described yet another modification of the sling procedure using the aponeurosis of the external oblique muscles, which most resembles the modern fascial sling. In his procedure, Aldridge harvested two strips of fascia, maintaining medial attachment, and passed the lateral arms inferiorly to be sutured suburethrally at the level of the urethrovesical junction. In the same report, Aldridge discussed the advantages of autologous fascia lata over abdominal wall fascia.1
A more recent modification was described by Raz and colleagues2 in 1989. In this report, an in situ vaginal wall patch was used suburethrally in conjunction with suture arms. Cure of stress incontinence was reported in 94% of patients with ISD.
Difficulties with autologous grafts include inadequate length or poor quality of the tissue and the complications of a harvesting technique (i.e., additional incision, risk of incisional hernia at harvesting site). Surgeons continued to search for the ideal graft material and switched to inorganic from organic graft materials. First reported was a nylon sling by Bracht in 1956.3 Later use of inorganic grafts included Silastic sheets (silicone), Mersilene, Marlex, and Gore-tex slings. In 1962, Williams and TeLinde4 reported the use of a Mersilene sling in 12 patients. Complications included abscess formation with a persistent sinus tract and urethral trauma. At the time the authors did not believe the Mersilene to be the etiology of the infection, but rather believed it to be the vaginal surgical route and therefore equal to a fascial sling. In 1985, Stanton and colleagues5 reported on 30 Silastic sling procedures with an 83% subjective and objective short-term cure rate. Silastic sheets were chosen because of the consistent strength, lack of incorporation into surrounding tissues, local fibrous sheath response, and therefore ease of removal, if necessary. In 1988, Horbach and associates6 reported on the use of Gore-tex slings with a short-term 85% subjective and objective cure rate. The tension-free vaginal tape sling procedure (TVT), first described in Sweden by Ulmsten and Petros7 in 1995, incorporated several different materials in the original series. Since 1996, however, the TVT procedure has used a unique prolene mesh sling.8,8a Complications of inorganic graft materials have included urinary retention requiring surgical revision, urethral irritation, necrosis, and graft infection and erosion.
A return to the use of organic materials has occurred with the use of allografts such as cadaveric fascia lata, dermis, pericardium, and dura, and heterologous grafts such as porcine small intestine submucosa and dermis.
As surgeons continue to search for the ideal graft material, organic (homologous and heterologous) and inorganic graft materials continue to be employed. No study has compared organic with inorganic grafts. As yet, the ideal material has not been identified, and the selection continues to be the surgeon's choice.
As recommended by the Agency for Health Care Policy and Research (AHCPR), all patients with complaints of urinary incontinence should undergo a basic evaluation that includes a medical history, physical examination, measurement of postvoid residual volume, and urinalysis. Particularly important in the history is a detailed exploration of the incontinence symptoms, including duration, frequency, precipitating factors, other lower urinary tract symptoms, and possible risk factors, including prior treatments. During the physical examination, a focus on the pelvic examination, with emphasis on site-specific support defects, will identify concurrent prolapse conditions while assessing the integrity of the urogenital tissue. Patients with a complicated history in terms of severity of disease, recurrence of symptoms, or presence of comorbid conditions should undergo further evaluation with urodynamic testing, endoscopy, and/or imaging studies.9
Genuine stress incontinence (GSI) is defined as the involuntary loss of urine occurring when, in the absence of a detrusor contraction, the intravesical pressure exceeds maximum urethral pressure.10 Patients with GSI are often categorized according to the presence or absence of urethral hypermobility. Early definitions of GSI classified patients as types I, II, and III. Type I is defined as straightening of the posterior urethrovesical angle to 180° or greater with straining. Type II consisted of the changes seen in type I, together with an increase of greater than 45° in the urethral axis in the vertical plane. Type III is associated with a fixed, “lead-pipe”, urethra.11
The term “intrinsic urethral sphincter deficiency” was first described by the AHCPR in 1992 as a cause of GSI.12 This condition is considered a more severe form of GSI and is defined as a subset of patients with GSI whose urethral sphincteric mechanisms fail to maintain sufficient resistance for urinary continence either at rest or in the presence of minimal physical exertion. The AHCPR guidelines recommend preoperative identification of patients with ISD, suggesting the use of various tests. However, despite these guidelines, a specific definition of ISD is not provided. Additional terms such as low-pressure urethra and type III incontinence have been used, but these entities are not interchangeable. Recommended management of the patient with ISD includes sling procedures, periurethral bulking agents, and artificial urethral sphincter.
Traditionally, as recommended by the AHCPR, sling procedures have been indicated in patients with either GSI caused by ISD or recurrent GSI. Expanded indications include patients with GSI with comorbid conditions that increase the risk of surgical failure. The high risk of surgical failure is associated with a tendency for repetitive increased abdominal pressure. High-risk conditions include chronic bronchitis/asthma, severe obesity, chronic steroid use, congenital tissue weakness, and a history of recreational or occupational heavy lifting or high impact.13
|INTRINSIC SPHINCTER DEFICIENCY|
Much clinical research has been done in an attempt to identify and define the patient with ISD. McGuire14 described a subset of patients whose symptoms had failed to respond to multiple operations for the treatment of stress incontinence. In this report, 75% of patients who failed to respond to multiple operations were defined as having type III incontinence (urinary loss associated with stress, with variable urethral mobility from none to marked, and urethral closure pressures less than 20 cm H2O). However, the finding of type III incontinence is not clearly noted as a cause of the surgical failure or an effect.
The association of multiple prior procedures with lower urethral closure pressure on urodynamic testing was confirmed in 1983 by Hilton and Stanton.15 In this report, continent and stress incontinent women were compared by urodynamic testing, specifically urethral pressure profilometry. Women with three or more prior anti-incontinence operations, age older than 60 years, and more severe symptoms of stress incontinence, as demonstrated objectively, were found to have lower mean maximum urethral closure pressures.
The relationship between low urethral closure pressure and outcome with a specific anti-incontinence procedure was later described.16 Subjects were grouped according to preoperative maximum urethral closure pressure (group 1, 20 cm H2O or less; group 2, more than 20 cm H2O), and all patients underwent Burch colposuspension (Tanagho modification). A 54% failure rate was seen in the low-pressure group. No significant difference was identified between the groups except for age. The low-pressure group was statistically older (mean age 53.3 years).
Further research evaluated 13 clinical characteristics as possible predictors of ISD, as defined by a maximum urethral closure pressure of 20 cm H2O or less.17 Clinical characteristics including age, gravidity, parity, estrogen status, prior hysterectomy, number and type of prior incontinence surgeries, associated presenting symptoms of urgency, frequency, or urge incontinence, maximum straining Q-tip angle, postvoid residual volume, and uroflow pattern were evaluated retrospectively. The only identifiable statistical predictor of ISD was an age older than 50 years.
Maximum urethral closure pressure evaluates the urethral sphincter mechanism at rest and therefore refers to the passive continence mechanism. An active test of the continence mechanism is the stress leak point pressure, either during a Valsalva maneuver or a cough. Comparison of maximum urethral closure pressure to stress leak point pressure in patients with GSI revealed a significant positive correlation. With stress leak point pressure as a diagnostic tool to define low-pressure urethra, a critical value of 45 cm H2O results in a sensitivity of 80% and a specificity of 90%. However, if stress leak point pressure is to be used as a screening tool, a critical value of 60 cm H2O shows an improved sensitivity of 90% with a reduced specificity of 64%.18
McLennan and Bent19 reported a comparison of stress leak point pressure and maximum urethral closure pressure with the supine empty stress test (postvoid residual volume less than 100 cc). The supine empty stress test was found to be a screening tool for low (60 cm H2O or less) stress leak point pressure but not for low (20 cm H2O or less) maximum urethral closure pressure. Similarly, Hsu and coworkers20 showed a sensitivity and specificity of at least 90% for the supine stress test (bladder volume = 200 cc) in comparison to low (100 cm H2O or less) stress leak point pressure.
Prior attempts to define the spectrum of GSI and its subset of patients with ISD by clinical and urodynamic evaluation emphasized age, prior surgical history, severity of incontinence history, extent of urethral mobility, maximum urethral closure pressure, and stress leak point pressure testing. In 1997, Bump and colleagues21 reported on the comparison of the latter three parameters. Low stress leak point pressure was consistently strongly associated with worse symptomatic incontinence. Sensitivities, specificities, and positive and negative predictive values among the three parameters were low, ranging from 40% to 85%. Subjects with all three parameters present had the worst incontinence. As previous work suggests, subjects with positive parameters were found to be significantly older and more likely to have had a prior hysterectomy or anti-incontinence or prolapse surgery, and averaged a higher number of prior procedures.
In summary, recommendations for the diagnosis of ISD included a composite of historic, urodynamic, anatomic, and clinical severity criteria.21
Once the incontinence workup is completed and the decision to proceed with a sling procedure has been made, options remain. First is the choice of graft material. Organic grafts require a harvesting procedure or can be obtained from a tissue bank. Autologous grafts include vaginal epithelium, rectus fascia, or fascia lata. Allografts include cadaveric dermis, fascia lata, dura, and pericardium. Heterologous grafts include porcine dermis and small intestine submucosa. Multiple inorganic grafts are readily available. Second is the choice of surgical approach. The various sling procedures performed today are technically somewhat similar. Most sling procedures are performed using a combined abdominal and vaginal approach, with most of the dissection performed vaginally. As reported in the early 1900s, a complete abdominal approach is possible but may be associated with increased urethral injury. Early avoidance of a combined procedure was common because of concern about vaginal contamination and increased postoperative infection. With today's improved surgical techniques and antibiotic coverage, combined abdominal and vaginal procedures are safe. Sling variations include a full-length sling, a patch sling, or a TVT sling.
As part of the preoperative preparation, the risks and benefits of the procedure, along with postoperative restrictions, are reviewed with the patient. Many surgeons teach all patients clean intermittent self-catheterization before surgery. On the day of surgery, the patient should receive appropriate antibiotic prophylaxis, according to patient allergy and medical history, 60 minutes before surgery. The patient is positioned in the dorsal lithotomy position and prepared and draped in a sterile fashion for abdominal and vaginal surgery. A Foley catheter is placed transurethrally.
If a full-length sling is planned, the graft of choice is prepared and soaked in antibiotic solution. If an autologous fascial graft is planned, a harvesting procedure for either fascia lata or rectus fascia is completed using a Wilson fascial stripper or a vein stripper. Similarly, if an allograft is used, this too should be hydrated in an antibiotic solution. Generally, the graft should measure approximately 2 ×12 to 18 cm for a full-length sling, according to patient habitus. A transverse suprapubic incision is made 2 fingerbreadths superior to the symphysis pubis, measuring approximately 4 cm. The underlying rectus fascia should be exposed with either sharp or blunt dissection. The anterior vaginal epithelium is then infiltrated with either sterile saline or dilute anesthetic/epinephrine solution. A midline anterior vaginal incision is made, measuring about 3 cm, at the level of the urethrovesical junction. The vaginal epithelium is sharply dissected away from the periurethral and perivesical tissue. The dissection should be completed laterally to the inferior pubic rami. Gentle traction is applied to the Foley catheter to allow identification and palpation of the balloon, indicating the urethrovesical junction. The bladder is decompressed. With the surgeon protecting the urethra with the nondominant hand, the perineal membrane is perforated bilaterally, allowing entrance into the space of Retzius, using either Metzenbaum or curved Mayo scissors at a 45° angle, always lateral to the urethra and directly behind the symphysis pubis (Fig. 1). The midportion of the sling is secured using delayed, absorbable suture along the proximal urethra, with the most proximal edge at the bladder base to prevent folding or kinking of the graft material. As is done with a needle urethropexy, packing forceps are passed with guidance from a vaginal finger, from the abdominal incision through the space of Retzius to the vaginal incision. The graft arm is grasped and carried back through to the abdominal incision. This is repeated on the opposite side (Fig. 2). When passing through the space of Retzius, the surgeon takes care to start medial to the pubic tubercle to avoid ilioinguinal nerve injury. Once both sling arms are passed, urethrocystoscopy is performed to rule out urethral or vesical injury. Ureteral function is also confirmed by intravenous indigo carmine injection. A suprapubic catheter is placed under cystoscopic guidance for postoperative bladder drainage and voiding trials. The sling arms are then sutured to the rectus fascia using permanent suture to allow a urethrovesical junction angle of 0° with the horizontal plane. The incisions are irrigated with antibiotic solution. The vaginal and abdominal incisions are reapproximated using delayed, absorbable suture (Fig. 3).
A variation of the full-length sling is the patch sling. This procedure can be performed with either a patch of in situ vagina, as described by Raz and associates in 1989,2 or other organic or inorganic grafts. The patch sling has been described as a variation of a Pereyra or Raz procedure.22 The patch should measure approximately 2 × 5 cm. Surgical preparation, the abdominal and vaginal incisions, and dissections are completed as described for the full-length sling. Entrance into the space of Retzius may or may not be accomplished, according to the surgeon's preference. As in the full-length sling procedure, the midportion of the patch graft is secured suburethrally using delayed, absorbable suture to prevent folding or kinking of the graft. In a helical fashion, permanent suture is passed along the long axis of the patch graft. A Stamey ligature carrier is passed with guidance from a vaginal finger, from the abdominal incision through the space of Retzius to the vaginal incision on each side for suture transfer. Once both suture arms have been transferred, urethrocystoscopy is performed after intravenous indigo carmine administration to rule out urethral, vesical, or ureteral injury. A suprapubic catheter is placed under cystoscopic guidance for postoperative bladder drainage and voiding trials. The suture arms are tied down to a urethrovesical junction angle of 0° with the horizontal plane. The incisions are irrigated with antibiotic solution. The vaginal and abdominal incisions are reapproximated using delayed, absorbable suture (see Fig. 3).
The full-length and patch sling procedures are most often performed under general anesthesia; however, if medically indicated, they may be completed under regional anesthesia.
Tension-Free Vaginal Tape Sling
The TVT system consists of a reusable stainless-steel introducer handle, a reusable rigid catheter guide, and the single-use device. The TVT device consists of a 1 × 40-cm ribbon of polypropylene mesh covered by a plastic sheath attached onto two curved stainless-steel needles (Fig. 4).
The TVT procedure is most often performed under local anesthesia with intravenous sedation. The procedure is performed with the patient in the dorsal lithotomy position with her lower extremities supported in Allen-type stirrups. An 18F Foley catheter is inserted to the urethra and the bladder is emptied. Local anesthetic is applied suprapubically at two points, 1 to 2 cm above the pubic symphysis and 2 to 3 cm lateral to the midline. The abdominal skin, underlying rectus muscle, and fascia as well as the posterior aspect of the pubic bone is infiltrated bilaterally. Two small abdominal skin incisions (0.5 to 1.0 cm) are then made at these points. No further abdominal dissection is necessary.
A Sims speculum is then inserted into the vagina to allow visualization of the anterior vaginal wall. The indwelling Foley bulb is used to identify the location of the internal urethral egress, while the external meatus is easily visualized. Using these two points as landmarks, the region of the midurethra is identified. The local anesthetic solution is injected into the vaginal submucosa in the midline and slightly lateral on each side of the urethra. Allis clamps are placed bilaterally for countertraction as a small sagittal incision (1.5 cm) is made in the midline at the level of midurethra. The incision should begin approximately 1 cm from the external urethral meatus. The Metzenbaum scissors are then used to minimally dissect the vaginal wall, freeing it from the underlying periurethral tissue and developing a small tunnel bilaterally. This dissection should be limited to a depth of 1 to 1.5 cm. Care should be taken not to puncture the pubocervical fascia or injure the urethra (Fig. 5). Additional local anesthetic solution should be injected bilaterally using a long spinal needle, placing the solution along the inferior and posterior aspects of the pubic symphysis.
The rigid catheter guide is then inserted into the Foley catheter. The handle of the rigid guide is then moved to the ipsilateral side of the anticipated passage of the forthcoming TVT needle. With the aid of the introducer handle, the surgeon places the tip of the needle into the previously developed periurethral tunnel (Fig. 6). Two hands are required to pass the needle safely. The needle is directed slightly laterally, most often in direct alignment with the patient's ipsilateral axilla. The TVT needle is gradually advanced by applying gentle pressure with the palm of the vaginal hand, with continued vaginal finger guidance and slight pressure from the second hand on the introducer handle. As the needle tip passes through the endopelvic fascia, a distinct drop in resistance is appreciated. At that point, with downward deflexion of the introducer handle, the surgeon guides the needle superiorly through the space of Retzius, with the needle being immediately opposed to the back side of the pubic symphysis (Fig. 7). As the needle opposes the underside of the rectus muscle and fascial sheath, resistance is again appreciated. At this point, the introducer handle is used solely to direct pressure anteriorly, advancing the needle tip through the previously made small abdominal incisions. The surgeon's nondominant hand is used suprapubically to help guide the needle tip (Fig. 8).
The rigid catheter guide and Foley catheter are removed and diagnostic urethrocystoscopy is performed to evaluate for any unintentional injury of the urethra or bladder. Once correct needle placement is confirmed, the needles pass completely through the abdominal incision. The steps of the procedure are then repeated on the opposite side. Care should be taken to ensure the tape is not twisted under the urethra (Fig. 9).
After correct placement of the TVT device and before removal of the protective plastic sheath, a cough test is performed to identify the correct positioning of the tape. The cough test is conducted with a full bladder (250 to 300 mL saline) (Fig. 10). Once the proper positioning of the tape is obtained, the plastic sheath is removed and the prolene mesh is left in place without tension under the midurethra. The abdominal ends of the tape are cut just below the skin surface. The procedure is completed with closure of the abdominal and vaginal incisions (Fig. 11).
All of the above sling procedures have been successfully reported in patients with recurrent stress incontinence as well as patients with ISD. Cure rates for sling procedures vary from 70% to 100%.23,24 Comparison of various sling case series is difficult, given the variation in surgical technique. No direct comparison study has been reported.
The use of inorganic graft materials in gynecologic and urologic surgery has developed from the use of these materials in general surgical techniques such as herniorrhaphy and orthopedic repairs. Inorganic materials can be compared by their mechanical and biologic properties.
Chemical components of inorganic grafts include monofilament and multifilament types. Monofilaments include polypropylene (Marlex, Prolene, and Atrium). Multifilaments include polytetrafluoroethylene (Teflon), expanded polytetrafluoroethylene (Gore-tex), polyethylene terephthalate (Mersilene), polyglycolic acid (Dexon), and polyglactin 910 (Vicryl). Of the multifilaments, only two are absorbable (Dexon and Vicryl). One theoretical disadvantage of multifilament mesh is that its interstices may allow penetration by small bacteria (less than 1 μm), but not larger macrophages and polymorphonuclear leukocytes. The porosity of the mesh also contributes to the development of fibrous tissue. The number, size, and shape of the pores appear to be related to tissue bonding. Mersilene is the most porous compared with Teflon and Marlex. Mesh flexibility is another property related to clinical outcome in that complications such as mesh extrusion may relate to the rigidity of the mesh.25
Organic grafts can be autologous or heterologous. Autologous grafts require a separate harvesting procedure. Allografts and heterologous grafts can be purchased from various tissue banks. It is recommended that grafts be purchased from accredited tissue banks. The American Association of Tissue Banks inspects the bank to ensure high- quality tissue production. Autologous grafts used include various muscles, rectus fascia, and fascia lata. Allografts include dermis, dura, pericardium, and fascia lata. Heterologous grafts include porcine small intestine submucosa (SIS) and porcine dermal collagen (Pelvicol). Alloderm is an acellular, freeze-dried, human dermal graft. Fascia lata grafts are available as either solvent-dehydrated, gamma-irradiated (Tutoplast) or freeze-dried (FasLata). Pericardium is available as a solvent-dehydrated, gamma-irradiated graft (Tutoplast).
Graft materials vary in mechanical and biologic properties. These properties are associated with a variety of success and complication rates when used in anti-incontinence surgery. Without randomized comparison studies, the decision remains with the surgeon. It is therefore of utmost importance that the surgeon be familiar with these graft materials and their properties.
The complications associated with sling procedures can be categorized as those common to anti-incontinence surgery (transvaginal or retropubic) and those specific to the sling technique.
Complications common to anti-incontinence surgery include injury to the bladder, urethra, or ureter, retropubic or vaginal hematoma, wound infection, cystitis, nerve damage, and recurrent or persistent urinary incontinence. The use of urethrocystoscopy at the time of sling procedures can aid in identifying intraoperative lower urinary tract injury, therefore allowing immediate attention and repair of the injury. Intraoperative hemorrhage and hematoma formation should be prevented by meticulous surgical technique. Knowledge and attention to surgical anatomy, as well as experience with the technique, are essential to avoidance and management of vascular injury. Nerve damage may occur secondary to positioning for abdominal or vaginal surgery. Injury is commonly due to compression or stretch of the nerve fibers but may also be secondary to direct transection. Attention to intraoperative positioning and surgical technique, along with early recognition and evaluation of any postoperative complaints, is recommended to avoid injury. Persistent or recurrent urinary incontinence can occur due to surgical failure, de novo or persistent detrusor instability,overflow incontinence, or fistula formation. This complication should be addressed with a thorough workup and appropriate treatment.
Complications specific to the sling procedure include voiding dysfunction and urinary retention, detrusor instability, and graft erosion and infection. Voiding dysfunction and urinary retention are associated with the level of tension of the sling and resultant outlet obstruction. Many techniques are used during surgery for sling adjustment, but no one method is recommended, and the selection remains a matter of the surgeon's experience. Rates of persistent urinary retention have been reported to be 2% to 10%.13,23,26 Symptomatic de novo postoperative detrusor instability is thought to be related to the degree of outflow obstruction. Reported rates vary from 2% to 22%.13 Graft erosion and infection have been reported with an increased incidence associated with inorganic materials. Due to the increased incidence of graft erosion and infection with inorganic materials, there has been a trend toward the use of organic grafts. Organic grafts, however, are not free of similar complications.
Few randomized controlled trials exist comparing sling procedures with colposuspensions.27 No randomized controlled trials exist comparing the various techniques of the suburethral sling procedure.
Variation exists with regard to surgical technique, graft material, and success and complication rates for the suburethral sling procedure. Despite this variation, the suburethral sling procedure is an effective, safe technique for the treatment of GSI and ISD.
6. Horbach NS, Blanco JS, Ostergard DR et al: A suburethral sling with polytetrafluoroethylene for the treatment of genuine stress incontinence in patients with low closure pressure. Obstet Gynecol 71: 648, 1988
8. Dietz HP, Vancaillie P, Svehla M et al: Mechanical properties of implant materials used in incontinence surgery [abstract 98]. 31st Annual Meeting of the International Continence Society, Seoul, Korea, 2001
9. Urinary Incontinence in Adults Guideline Update Panel. Urinary Incontinence in Adults: Acute and Chronic Management, Clinical Practice Guideline. AHCPR Pub No. 96-0682. Agency for Health Care Policy and Research, Public Health Service, U.S. Dept. of Health and Human Services, March 1996
21. Bump RC, Coates KW, Cundiff GW et al: Diagnosing intrinsic sphincteric deficiency: comparing urethral closure pressure, urethral axis, and Valsalva leak point pressures. Am J Obstet Gynecol 177: 303, 1997